SNHG20 is an aberrant expression in various cancers and promotes the development and progression of tumors, such as hepatocellular carcinoma, ovarian cancer, colorectal cancer, and bladder cancer (44). This evidence concerns the gene SNHG20 and urinary bladder cancer.